Pharma and laboratory597800-2026

Denmark – Pharmaceutical products – Amgros 2027 2.1308.a

Amgros I/S

Buyer country

Denmark

Publication date

31 August 2026

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
38 days to indexed deadline

08 October 2026

Indexed data completeness
100%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33600000

Medical equipment, pharmaceuticals and personal care products

90-day market activity
6 related notices

2 buyers in Denmark / Pharma and laboratory

Buyer activity
5 indexed notices

Published by this buyer in the last 90 days

Market context

How this notice compares with the current market

Biderra found 6 pharma and laboratory notices from Denmark in its rolling 90-day index. 83% publish an estimated value and 67% include at least one indexed deadline. This notice is currently active according to the deadline fields available in the source feed.

Recent notices

6

Value disclosed

83%

Deadline coverage

67%

Related active opportunities

More pharma and laboratory notices from Denmark

View the full market

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Dinamarca – Productos farmacéuticos – Amgros 2027 2.1308.a

Dutch

Denemarken – Farmaceutische producten – Amgros 2027 2.1308.a

Polish

Dania – Produkty farmaceutyczne – Amgros 2027 2.1308.a

French

Danemark – Produits pharmaceutiques – Amgros 2027 2.1308.a

German

Dänemark – Arzneimittel – Amgros 2027 2.1308.a

Italian

Danimarca – Prodotti farmaceutici – Amgros 2027 2.1308.a

English

Denmark – Pharmaceutical products – Amgros 2027 2.1308.a

What Biderra adds

For notice 597800-2026, Biderra has normalized the contracting authority country as Denmark, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.